These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37336272)

  • 1. Prognostic and immunological role of Asporin across cancers and exploration in bladder cancer.
    Wei F; Li T; Li J; Zhang Y; Liu T; Zhao Z; Zhu W; Guo H; Yang R
    Gene; 2023 Aug; 878():147573. PubMed ID: 37336272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.
    Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y
    PeerJ; 2023; 11():e15284. PubMed ID: 37123010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
    Front Immunol; 2023; 14():955949. PubMed ID: 37006317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-628-5p is a Potential Novel Prognosis Biomarker, Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
    Huang H; Xu Q; Zhang Y; Zhou Y; Ma K; Luo Y
    Curr Pharm Des; 2023; 29(31):2477-2488. PubMed ID: 37916623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancancer Analysis of the Oncogenic and Prognostic Role of
    Liu Q; Xie R; Li Y
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
    Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
    BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA.
    Shi K; Zhou J; Li M; Yan W; Zhang J; Zhang X; Jiang L
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166965. PubMed ID: 38000776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma.
    Li P; Qiao G; Lu J; Ji W; Gao C; Qi F
    Math Biosci Eng; 2022 Jan; 19(1):169-190. PubMed ID: 34902986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.
    Mi Y; Wang X
    J Environ Pathol Toxicol Oncol; 2022; 41(3):1-12. PubMed ID: 35993952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress.
    Sasaki Y; Takagane K; Konno T; Itoh G; Kuriyama S; Yanagihara K; Yashiro M; Yamada S; Murakami S; Tanaka M
    Cancer Sci; 2021 Mar; 112(3):1251-1261. PubMed ID: 33393151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
    Ni W; Yi L; Dong X; Cao M; Zheng J; Wei Q; Yuan C
    Sci Rep; 2023 Feb; 13(1):2051. PubMed ID: 36739300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
    Zhu L; Liu X; Zhang W; Hu H; Wang Q; Xu K
    BMC Cancer; 2022 May; 22(1):556. PubMed ID: 35581573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic Asporin promotes cell migration by regulating TGF-β/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer.
    Li H; Zhang Z; Chen L; Sun X; Zhao Y; Guo Q; Zhu S; Li P; Min L; Zhang S
    Cell Death Dis; 2019 Feb; 10(2):109. PubMed ID: 30728352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASPN Is a Potential Biomarker and Associated with Immune Infiltration in Endometriosis.
    Wang L; Sun J
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.
    Huang Z; Yan Y; Wang T; Wang Z; Cai J; Cao X; Yang C; Zhang F; Wu G; Shen B
    J Transl Med; 2022 Jul; 20(1):315. PubMed ID: 35836227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression.
    Liu B; Pan S; Liu J; Kong C
    Gene; 2021 Apr; 775():145451. PubMed ID: 33482279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():975503. PubMed ID: 36072584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
    Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C
    DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.